- $2.10m
- $22.16m
- $32.95m
Annual income statement for Omniq, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2021 December 31st | 2022 December 31st | 2023 December 31st | R2024 December 31st | 2025 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 78.3 | 103 | 81.2 | 34.9 | 33 |
| Cost of Revenue | |||||
| Gross Profit | 16.7 | 22.1 | 15.7 | 5.63 | 9.04 |
| Selling / General / Administrative Expenses | |||||
| Research And Development | |||||
| Depreciation and Amortization | |||||
| Unusual Expense / Income | |||||
| Total Operating Expenses | 88.7 | 112 | 107 | 41.5 | 36.8 |
| Operating Profit | -10.5 | -9.55 | -26.2 | -6.62 | -3.85 |
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | -13 | -13.6 | -30.1 | -8.17 | -0.533 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | -13.1 | -13.6 | -29.4 | -7.47 | -1.03 |
| Minority Interest | |||||
| Net Income Before Extraordinary Items | |||||
| Extraordinary Items | |||||
| Net Income | -13.4 | -13.7 | -29.4 | -10 | -0.137 |
| Adjustments to Net Income | |||||
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | -13.4 | -13.9 | -29.5 | -10 | -0.169 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | -2.21 | -1.83 | -2.37 | -0.701 | -0.095 |